KOL KNOCKOUT™: Retina Edition | Challenging Cases & Expert Opinions - Round 3, The Finale

KOL KNOCKOUT Retina Edition  Challenging Cases  Expert Opinions  Round 3 The Finale
Media formats available:
Details
Presenters
  • Overview

    Back by popular demand, this fun and exciting game show-style CME program features key opinion leaders (KOLs) as contestants. Hosted by Dr. Sunil K. Srivastava, the final round will feature the winners of the previous two rounds, Drs. J. Michael Jumper & Yoshihiro Yonekawa, battling it out with Dr. Ajay E. Kuriyan!

    There will be learning, laughter, and only one KOL left standing!  

    This activity is supported by an independent educational grant from Genentech, a member of the Roche Group.

     

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Appraise medical and surgical management approaches for common retinal diseases and their sequelae
    • Diagnose vitreoretinal pathology by performing thorough clinical exams and using advanced imaging modalities
    • Discuss how fluidics, intraocular tamponades, cutting rates, and gauge of surgery can impact surgical outcomes
    • Accreditation

      Provided by Evolve Medical Education 

      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
      Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

    • Faculty and Disclosures

      Sunil K. Srivastava, MD

      Sunil K. Srivastava, MD

      Surgical Retina Fellowship Director

      Cleveland Clinic

      Cole Eye Institute

      Cleveland, OH


      J. Michael Jumper, MD, FASRS

      J. Michael Jumper, MD, FASRS

      West Coast Retina
      Vice Chairman
      Department of Ophthalmology
      California Pacific Medical Center
      San Francisco, CA


      Ajay E. Kuriyan, MD, MS

      Ajay E. Kuriyan, MD, MS

      Wills Eye Physicians

      Mid Atlantic Retina 

      Associate Professor of Ophthalmology

      Sidney Kimmel Medical College

      Thomas Jefferson University

      Philadelphia, PA


      Yoshihiro Yonekawa, MD

      Yoshihiro Yonekawa, MD

      Associate Professor of Ophthalmology
      Wills Eye Hospital, Mid Atlantic Retina
      Thomas Jefferson University
      Philadelphia, PA


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Sunil K. Srivastava, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Adverum Biotechnologies, Bausch + Lomb, Carl Zeiss Meditec, EyePoint Pharmaceuticals, Eyevensys, and Novartis. Grant/Research Support: Bausch + Lomb, EyePoint Pharmaceuticals, Eyevensys, and Regeneron.

      J. Michael Jumper, MD, FASRS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: EyeBio. Grant/Research Support: Acelyrin, Genentech, and Regenxbio. Shareholder: EyeBio.

      Ajay E. Kuriyan, MD, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alimera Sciences, Allergan, Bausch + Lomb, EyePoint Pharmaceuticals, Genentech/Roche, Novartis, Optos, RecensMedical, and Spark Therapeutics. Grant/Research Support: Adverum Biotechnologies, Alcon Research Institute Young Investigator Award, Annexon, Genentech/Roche, Macula Society Young Investigator Award, and Retina Society Research Award. Speaker’s Bureau: Spark Therapeutics and Optos. Stock/Shareholder: RecensMedical.

      Yoshihiro Yonekawa, MD,has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch Health, EyePoint Pharmaceuticals, Regeneron, and Versant Health. Grant/Research Support: Genentech, Janssen, Kodiak, and Regeneron.

      The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Genentech, a member of the Roche Group.

      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free